Aurobindo gets approval for Losartan Potassium tabs

16108 Investors following Aurobindo Pharm. Share this News with them.

0

Like this story, share it with millions of investors on M3

Aurobindo gets approval for Losartan Potassium tabs

Aurobindo Pharma Limited is pleased to announce that it has received the tentative approval to manufacture and market Losartan Potassium tablets in the strengths 25mg, 50mg and 100mg from the US Food & Drug Administration

Post your opinion here

 

0

Tweet

Share on Tumblr

RELATED NEWS Aurobindo gets approval for cefazolin for injection USP Aurobindo Pharma gets approval for Alendronate Sodium Tabs Aurobindo Pharma cons revenues up 27.6% to Rs 684.7cr ALSO READ See latest News about Aurobindo Pharm See previous management interviews See what other Experts & Brokerages are saying about Aurobindo Pharm Aurobindo Pharm BSE | NSE 25/05/12 Are Mutual Funds betting on Aurobindo Pharm?

Aurobindo Pharma Limited is pleased to announce that it has received the tentative approval to manufacture and market Losartan Potassium tablets in the strengths 25mg, 50mg and 100mg from the US Food & Drug Administration (USFDA).

Losartan Potassium tablets are the generic equivalent of Merck Research Laboratories Cozaar® Tablets 25mg, 50mg and 100mg and falls in the anti-hypertensive segment. The branded sales of Losartan range of products was USD 1235 million for the year ended December 2007 according to Merck Financial Disclosures

This is Aurobindo's 75th ANDA approval from USFDA. 

Sourced From: Aurobindo Pharma Limited